Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors.
Saved in:
| Title: | Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. |
|---|---|
| Authors: | Schoenfeld AJ; Division of Solid Tumor Oncology, Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York., Lee SM; Clinical Research Division, Department of Medicine, Fred Hutchinson Cancer Center, Seattle, Washington., Doger de Spéville B; TART Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Gettinger SN; Division of Medical Oncology, Department of Medicine, Yale Cancer Center, North Haven, Connecticut., Häfliger S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Sukari A; Department of Oncology, Barbara Ann Karmanos Cancer Hospital, Detroit, Michigan., Papa S; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Rodríguez-Moreno JF; Department of Medical Oncology, Hospital Universitario HM Sanchinarro, Centro Integral Oncológico Clara Campal, Madrid, Spain., Graf Finckenstein F; Iovance Biotherapeutics, Inc., San Carlos, California., Fiaz R; Iovance Biotherapeutics, Inc., San Carlos, California., Catlett M; Iovance Biotherapeutics, Inc., San Carlos, California., Chen G; Iovance Biotherapeutics, Inc., San Carlos, California., Qi R; Iovance Biotherapeutics, Inc., San Carlos, California., Masteller EL; Iovance Biotherapeutics, Inc., San Carlos, California., Gontcharova V; Iovance Biotherapeutics, Inc., San Carlos, California., He K; Division of Medical Oncology, Department of Internal Medicine, Thoracic Oncology Program, Ohio State University, Columbus, Ohio. |
| Source: | Cancer discovery [Cancer Discov] 2024 Aug 02; Vol. 14 (8), pp. 1389-1402. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38563600 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schoenfeld+AJ%22">Schoenfeld AJ</searchLink>; Division of Solid Tumor Oncology, Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.<br /><searchLink fieldCode="AU" term="%22Lee+SM%22">Lee SM</searchLink>; Clinical Research Division, Department of Medicine, Fred Hutchinson Cancer Center, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Doger+de+Spéville+B%22">Doger de Spéville B</searchLink>; TART Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gettinger+SN%22">Gettinger SN</searchLink>; Division of Medical Oncology, Department of Medicine, Yale Cancer Center, North Haven, Connecticut.<br /><searchLink fieldCode="AU" term="%22Häfliger+S%22">Häfliger S</searchLink>; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Sukari+A%22">Sukari A</searchLink>; Department of Oncology, Barbara Ann Karmanos Cancer Hospital, Detroit, Michigan.<br /><searchLink fieldCode="AU" term="%22Papa+S%22">Papa S</searchLink>; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Moreno+JF%22">Rodríguez-Moreno JF</searchLink>; Department of Medical Oncology, Hospital Universitario HM Sanchinarro, Centro Integral Oncológico Clara Campal, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Graf+Finckenstein+F%22">Graf Finckenstein F</searchLink>; Iovance Biotherapeutics, Inc., San Carlos, California.<br /><searchLink fieldCode="AU" term="%22Fiaz+R%22">Fiaz R</searchLink>; Iovance Biotherapeutics, Inc., San Carlos, California.<br /><searchLink fieldCode="AU" term="%22Catlett+M%22">Catlett M</searchLink>; Iovance Biotherapeutics, Inc., San Carlos, California.<br /><searchLink fieldCode="AU" term="%22Chen+G%22">Chen G</searchLink>; Iovance Biotherapeutics, Inc., San Carlos, California.<br /><searchLink fieldCode="AU" term="%22Qi+R%22">Qi R</searchLink>; Iovance Biotherapeutics, Inc., San Carlos, California.<br /><searchLink fieldCode="AU" term="%22Masteller+EL%22">Masteller EL</searchLink>; Iovance Biotherapeutics, Inc., San Carlos, California.<br /><searchLink fieldCode="AU" term="%22Gontcharova+V%22">Gontcharova V</searchLink>; Iovance Biotherapeutics, Inc., San Carlos, California.<br /><searchLink fieldCode="AU" term="%22He+K%22">He K</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Thoracic Oncology Program, Ohio State University, Columbus, Ohio. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101561693%22">Cancer discovery</searchLink> [Cancer Discov] 2024 Aug 02; Vol. 14 (8), pp. 1389-1402. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase II; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101561693 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-8290 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221598274%22">21598274 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Discov <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38563600 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2159-8290.CD-23-1334 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1389 Titles: – TitleFull: Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schoenfeld AJ – PersonEntity: Name: NameFull: Lee SM – PersonEntity: Name: NameFull: Doger de Spéville B – PersonEntity: Name: NameFull: Gettinger SN – PersonEntity: Name: NameFull: Häfliger S – PersonEntity: Name: NameFull: Sukari A – PersonEntity: Name: NameFull: Papa S – PersonEntity: Name: NameFull: Rodríguez-Moreno JF – PersonEntity: Name: NameFull: Graf Finckenstein F – PersonEntity: Name: NameFull: Fiaz R – PersonEntity: Name: NameFull: Catlett M – PersonEntity: Name: NameFull: Chen G – PersonEntity: Name: NameFull: Qi R – PersonEntity: Name: NameFull: Masteller EL – PersonEntity: Name: NameFull: Gontcharova V – PersonEntity: Name: NameFull: He K IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 08 Text: 2024 Aug 02 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2159-8290 Numbering: – Type: volume Value: 14 – Type: issue Value: 8 Titles: – TitleFull: Cancer discovery Type: main |
| ResultId | 1 |
